Among them, INPP5F has been recently demonstrated to be an oncogene that activates the ASPH-mediated Notch-c-MYC/cyclin E1 pathway in hepatocellular carcinoma (57). This evidence concerns the gene ASPH and hepatocellular carcinoma.